Searchable abstracts of presentations at key conferences in endocrinology

ea0081oc8.5 | Oral Communications 8: Calcium and Bone | ECE2022

Key4OI: Development and implementation of a standard set of outcome measures for osteogenesis imperfecta

Franken Anton , Mekking Dagmar

Key4OI : Development and implementation of a Standard set of Outcome measures for Osteogenesis Imperfecta. Osteogenesis Imperfecta (OI) is a genetic disorder also known as ‘brittle bone disease’. The clinical manifestation of OI shows a wide variation. Therefore, care for patients with OI requires an interdisciplinary approach. The effectiveness of particular interventions and treatment protocols of interdisciplinary teams is not clear due to a non-standardized and w...

ea0047oc44 | Innovative Theranostics | Theranostics2016

Critical aspects of radiochemical purity determination of 68Ga-BCA-peptides and behavioral features of different 68Ga species

Larenkov Anton A , Maruk Alesya Ya

Determination of radiochemical purity (RCP) of radiopharmaceuticals based on 68Ga-BCA-peptides (68Ga-DOTA-TOC/-TATE, 68Ga-NODAGA-RGD2, 68Ga-PSMA-HBED-CC, etc.) is an extremely important part of QC in routine clinical practice. Nature of gallium leads to formation of two major radiochemical impurities in the radiopharmaceutical: hydrolyzed 68Ga (colloid) and unbounded ionic forms of 68Ga. The amounts o...

ea0016p401 | Neuroendocrinology | ECE2008

Serum and glucocorticoid-induced kinase 1 mediates basal and stimulated POMC transcription in pituitary corticotrophs

Helene Reiter Marie , Vila Greisa , Luger Anton

Cushing’s tumours are ACTH-producing neoplasms of the pituitary gland. Their ACTH-oversecretion is autonomous and does not respond to the canonical inhibition of the hence also elevated cortisol. Current research in identifying new drug targets is mainly focused on designing therapeuticals that directly inhibit ACTH over-secretion from the adenoma. Serum and glucocorticoid-induced kinase 1 (Sgk1) is an early target gene of glucocorticoids in all cells studied. It is a PKB...

ea0081rc2.5 | Rapid Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Treatment of adrenal insufficiency in the netherlands from a patient perspective in the recent past. Lessions learned for europe

Franken Anton , van der Vlugt Roselinda , Beun Johan

In 2015 AdrenalNET organized a roundtable conference with patient representatives, prescribers and pharmaceutical industry. The cause of this meeting was complaints of patients about the problematic hydrocortisone market in the Netherlands, characterized by frequent availability issues (shortage ) of the hydrocortison tablets/capsules and frequent changes in manufacturers (compounding companies) leading to quality issues. All parties at the roundtable meeting agreed to join fo...

ea0063p150 | Diabetes, Obesity and Metabolism 1 | ECE2019

Effects of diabetes mellitus and autoimmune thyroiditis on features of rheumatoid arthritis

Dvorovkin Anton , Odin Vitaly , Tyrenko Vadim , Toporkov Michael

Background: It is known that rheumatoid arthritis (RA) can be a part of autoimmune polyglandular syndrome and be combined with endocrine diseases.Objectives: To study the effects of autoimmune thyroiditis (AIT) and diabetes mellitus (DM) on the clinical and laboratory manifestations of RA.Methods: The study included two groups of patients. The first group of patients included 24 patients (20 women and 4 men, mean age - 68.37±1...

ea0070oc5.7 | Thyroid | ECE2020

Triiodothyronine (T3) use in hypothyroidism and effects on cancer and mortality

Planck Tereza , Hedberg Fredric , Calissendorff Jan , Nilsson Anton

Background: The prescription of triiodothyronine (T3) for hypothyroidism is increasing worldwide, however, long-term effects of its use are largely unknown. Previous studies have suggested possible association between T3 use and breast cancer. The aim of the study was to examine the effects of T3 use on cancer incidence and mortality.Material: Our sample included the full adult population of individuals living in Sweden with at least three purchases of t...

ea0032p1054 | Thyroid (non-cancer) | ECE2013

Learning and development of thyroid FNA in a endocrine clinic

Lorenzo Jaime , Ruth Boente , Yosu Anton , Sas Manuel

Background: Development of thyroid ultrasound and FNA is more frecuent to make it in a endocrine clinic, that means to make more diagnosis medical process and so to avoid more outpatients visits. But it’s neccesary a specific treaning. We tried to evaluated our treaning.Material and methods: After specific treating in radiologic department, we have compared our results in two consecutive periods. The first one in the first year after treaning develo...

ea0028s5.2 | Sprint or marathon: muscling in on the Olympics | SFEBES2012

Exercise effects on fat metabolism and insulin sensitivity in human muscle

Wagenmakers Anton , Shepherd Sam , van Loon Luc , Shaw Christopher

There is an accumulating amount of evidence that the metabolic adaptations to endurance exercise that result in increased intramuscular triglyceride (IMTG) stores and IMTG oxidation during exercise, also exert a protective effect on muscle insulin sensitivity. This seems to be a contradiction (known as the athlete's paradox) as large IMTG stores in sedentary and obese individuals coexist with high levels of fatty acid (FA) metabolites (specifically long-chain acylCoA, DAG and ...

ea0014p280 | (1) | ECE2007

Non-genomic glucocorticoid effects on insulin secretion

Vila Greisa , Wagner Ludwig , Nabokikh Anastasia , Luger Anton

Glucocorticoids act directly on pancreatic islets suppressing insulin secretion from the beta cells through a genomic mechanism of slow onset. We present here data on immediate actions of dexamethasone on two models of insulin secretion: RINm5F and INS-1 beta cell lines. Under normal glucose concentrations, dexamethasone rapidly (within minutes) decreased insulin secretion about 30%. Under hypoglycaemic conditions (glucose reduced to 50% for 1 hour) dexamethasone increased ins...

ea0081p46 | Calcium and Bone | ECE2022

Bleeding assessment in 195 patients with osteogenesis imperfecta

Gooijer Koert , Heidsieck Gabriela , Harsevoort Arjan , Bout Danielle , Janus Guus , Franken Anton

Background: Osteogenesis Imperfecta (OI) is commonly defined as ‘brittle bones’ disease, but there are also more characteristics like blue sclerae, hearing loss, dental problems, ligamentous laxity and a short stature. Easy bruising is also a very common feature and there are multiple case reports on haemorrhagic events in OI. Larger population studies on bleeding tendency in OI are very sparse, while other connective tissue disorders with easy bruising have much mor...